title: Effect of oral contraceptives on the renin angiotensin system and renal function.
abstract: We examined the effect of oral contraceptive (OC) usage on the renin angiotensin system (RAS) in two related experiments. In the first experiment, subjects were 34 healthy, normotensive, premenopausal women, 15 OC users and 19 OC nonusers, mean age 25 +/- 1 yr, ingesting a controlled sodium diet. We assessed arterial pressure, glomerular filtration rate, effective renal plasma flow, renal vascular resistance (RVR), and filtration fraction (FF) using inulin and p-aminohippurate clearance techniques, both at baseline and in response to the ANG II receptor blocker losartan. In the second experiment, in similar subjects, 10 OC users and 10 nonusers, we examined circulating RAS components [angiotensinogen, ANG II, aldosterone, plasma renin activity (PRA), and active renin] in response to incremental lower body negative pressure (LBNP), to determine whether renin secretion is suppressed by OC usage. OC users exhibited elevations in systolic blood pressure, RVR, and FF compared with nonusers, which were partially corrected by losartan. In the LBNP phase of the study, baseline measures of PRA, angiotensinogen, ANG II, and aldosterone were all increased in the OC group compared with the control group. Active renin levels did not differ between groups. Incremental LBNP resulted in increased circulating levels of RAS components in both groups. We conclude that the RAS is activated in women using OCs. There was no evidence that decreases in renin secretion result in normalization of the RAS as a whole.
authors.affiliation: Department of Medicine, University of Toronto, Toronto, Canada M5S 1A1.
authors.forename: A K
authors.initials: AK
authors.lastname: Kang
authors.forename: J A
authors.initials: JA
authors.lastname: Duncan
authors.forename: D C
authors.initials: DC
authors.lastname: Cattran
authors.forename: J S
authors.initials: JS
authors.lastname: Floras
authors.forename: V
authors.initials: V
authors.lastname: Lai
authors.forename: J W
authors.initials: JW
authors.lastname: Scholey
authors.forename: J A
authors.initials: JA
authors.lastname: Miller
mesh_terms: D000328:Adult; D000450:Aldosterone / Q000097:blood; D000804:Angiotensin II / Q000097:blood; D057911:Angiotensin Receptor Antagonists; D000808:Angiotensinogen / Q000097:blood; D001794:Blood Pressure; D003276:Contraceptives, Oral / Q000009:adverse effects*; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D007444:Inulin; D007668:Kidney / Q000098:blood supply / Q000187:drug effects* / Q000502:physiology*; D019808:Losartan / Q000494:pharmacology; D017697:Premenopause; D012079:Renal Circulation; D012083:Renin / Q000097:blood; D012084:Renin-Angiotensin System / Q000187:drug effects*; D014655:Vascular Resistance; D010130:p-Aminohippuric Acid
chemical_list: D057911:Angiotensin Receptor Antagonists; D003276:Contraceptives, Oral; D000808:Angiotensinogen; D000804:Angiotensin II; D000450:Aldosterone; D007444:Inulin; D012083:Renin; D019808:Losartan; D010130:p-Aminohippuric Acid